STERIS Price to Free Cash Flow Ratio 2010-2022 | STE

Historical price to free cash flow ratio values for STERIS (STE) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
STERIS Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2023-01-27 206.10 50.37
2022-09-30 165.84 $4.09 40.53
2022-06-30 205.12 $4.77 43.03
2022-03-31 240.07 $4.06 59.16
2021-12-31 241.24 $4.30 56.07
2021-09-30 202.09 $4.44 45.55
2021-06-30 203.68 $4.92 41.43
2021-03-31 187.67 $5.25 35.75
2020-12-31 186.31 $5.58 33.36
2020-09-30 172.83 $4.71 36.69
2020-06-30 150.12 $4.53 33.14
2020-03-31 136.60 $4.44 30.77
2019-12-31 148.43 $3.98 37.31
2019-09-30 140.36 $4.06 34.54
2019-06-30 144.26 $3.97 36.37
2019-03-31 123.76 $4.16 29.76
2018-12-31 102.99 $3.87 26.63
2018-09-30 109.94 $3.74 29.39
2018-06-30 100.62 $3.80 26.45
2018-03-31 89.20 $3.43 25.98
2017-12-31 83.29 $3.37 24.70
2017-09-30 83.88 $3.27 25.67
2017-06-30 77.05 $2.92 26.41
2017-03-31 65.44 $2.97 22.00
2016-12-31 63.23 $3.65 17.34
2016-09-30 68.31 $2.54 26.88
2016-06-30 63.99 $2.09 30.57
2016-03-31 65.89 $1.81 36.33
2015-12-31 69.60 $1.17 59.51
2015-09-30 60.02 $2.19 27.35
2015-06-30 59.53 $2.60 22.91
2015-03-31 64.92 $2.69 24.12
2014-12-31 59.91 $2.58 23.19
2014-09-30 49.85 $2.74 18.16
2014-06-30 49.41 $2.35 21.06
2014-03-31 44.11 $2.14 20.58
2013-12-31 44.39 $1.78 24.98
2013-09-30 39.50 $1.80 21.96
2013-06-30 39.23 $1.79 21.97
2013-03-31 37.91 $2.39 15.89
2012-12-31 31.49 $2.38 13.22
2012-09-30 31.98 $2.10 15.21
2012-06-30 28.13 $2.25 12.51
2012-03-31 28.18 $1.40 20.09
2011-12-31 26.44 $1.23 21.54
2011-09-30 25.80 $0.64 40.12
2011-06-30 30.65 $0.34 89.95
2011-03-31 30.13 $0.69 43.56
2010-12-31 31.66 $1.40 22.60
2010-09-30 28.73 $2.33 12.34
2010-06-30 26.74 $2.97 9.00
2010-03-31 28.86 $3.10 9.32
2009-12-31 23.90 $4.62 5.17
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $20.456B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $226.442B 23.68
Edwards Lifesciences (EW) United States $48.354B 33.28
Alcon (ALC) Switzerland $36.722B 31.62
Teleflex (TFX) United States $11.305B 18.34
Fresenius Medical Care AG KGaA (FMS) Germany $10.584B 10.62
Penumbra (PEN) United States $9.289B 2223.46
Globus Medical (GMED) United States $7.506B 38.16
Integer Holdings (ITGR) United States $2.380B 19.11
Glaukos (GKOS) United States $2.298B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.402B 19.97
Paragon 28 (FNA) United States $1.303B 0.00
Nevro (NVRO) United States $1.291B 0.00
Artivion (AORT) United States $0.505B 0.00